Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.
2.

Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.

Lücke CD, Philpott A, Metcalfe JC, Thompson AM, Hughes-Davies L, Kemp PR, Hesketh R.

Cancer Res. 2001 Jan 15;61(2):482-5.

4.

Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer.

Chen T, Jackson CR, Link A, Markey MP, Colligan BM, Douglass LE, Pemberton JO, Deddens JA, Graff JR, Carter JH.

Clin Cancer Res. 2006 Jan 15;12(2):392-7.

5.

Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.

Takenoshita S, Mogi A, Tani M, Osawa H, Sunaga H, Kakegawa H, Yanagita Y, Koida T, Kimura M, Fujita KI, Kato H, Kato R, Nagamachi Y.

Oncol Rep. 1998 Mar-Apr;5(2):367-71.

PMID:
9468559
6.

Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer.

Chen T, Carter D, Garrigue-Antar L, Reiss M.

Cancer Res. 1998 Nov 1;58(21):4805-10.

7.

Mutation analysis of the transforming growth factor beta type II receptor in sporadic human cancers of the pancreas, liver, and breast.

Vincent F, Hagiwara K, Ke Y, Stoner GD, Demetrick DJ, Bennett WP.

Biochem Biophys Res Commun. 1996 Jun 25;223(3):561-4.

PMID:
8687435
8.

Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.

Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y, Takenoshita S.

Cancer Res. 2000 Aug 15;60(16):4507-12.

9.
11.

Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer.

Gemma A, Seike M, Seike Y, Uematsu K, Hibino S, Kurimoto F, Yoshimura A, Shibuya M, Harris CC, Kudoh S.

Genes Chromosomes Cancer. 2000 Nov;29(3):213-8.

PMID:
10992296
13.

Mutational analysis of the transforming growth factor beta receptor type I gene in primary non-small cell lung cancer.

Zhang HT, Fei QY, Chen F, Qi QY, Zou W, Wang JC, Zhang RM, Tao SH, Chen XF, Luo ZW.

Lung Cancer. 2003 Jun;40(3):281-7.

PMID:
12781426
14.
15.

Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.

Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG.

Oncogene. 2000 Sep 21;19(40):4660-7.

17.

SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.

Woodford-Richens KL, Rowan AJ, Gorman P, Halford S, Bicknell DC, Wasan HS, Roylance RR, Bodmer WF, Tomlinson IP.

Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9719-23. Epub 2001 Jul 31.

18.
19.

Novel mutations in the polyadenine tract of the transforming growth factor beta type II receptor gene are found in a subpopulation of human pancreatic adenocarcinomas.

Venkatasubbarao K, Ahmed MM, Swiderski C, Harp C, Lee EY, McGrath P, Mohiuddin M, Strodel W, Freeman JW.

Genes Chromosomes Cancer. 1998 Jun;22(2):138-44.

PMID:
9598801
20.

Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.

Wang QS, Guda K, Papanikolaou A, Dong M, Rosenberg DW.

Int J Oncol. 2000 Sep;17(3):551-8.

PMID:
10938397

Supplemental Content

Support Center